Clinical Trials Are Becoming More Diverse, But There’s Still Work To Do
TUESDAY, Nov. 30, 2021 (HealthDay News) — U.S. cancer clinical trial participants have become more diverse in makeup, but certain groups remain underrepresented, a new study finds. It’s important to have a wide range of participants in clinical trials, to find out if treatments are safe and effective for peopleContinue Reading